Literature DB >> 11458622

Clinical spectrum of Kawasaki disease in infants.

C F Tseng1, Y C Fu, L S Fu, H Betau, C S Chi.   

Abstract

BACKGROUND: Kawasaki disease is a common acquired heart disease in children. Only a few reports have been published concerning Kawasaki disease in infants. This study was performed to assess the clinical spectrum of Kawasaki disease in infants.
METHODS: Between January 1989 and December 1998, a total of 48 consecutive Kawasaki patients less than one year of age were enrolled and studied retrospectively. Coronary artery dilation was defined as the internal diameter of a coronary artery larger than 3 mm. All cases received 2 gm/Kg of intravenous immunoglobulin. We divided the patients into two groups; group I; coronary artery dilation (+) and group II; coronary artery dilation (-), and compared the clinical and laboratory data.
RESULTS: Of 273 patients with Kawasaki disease, 48 (17.5%) were less than one year of age. Among these patients (< 1 year old), the median age was 7.8 +/- 2.8 months (range 2 months to 12 months), and the male to female ratio was 1.52:1. The incidence of atypical Kawasaki disease was 31.2% (compared with an incidence of atypical Kawasaki disease among patient more than one year of age of 7.5%; p < 0.001), and that of coronary artery dilation was 35.4%. Clinical manifestations included fever 100%, extremity change 91.6%, skin rash 89.6%, conjunctivitis 89.6%, oral mucosa change 89.6%, and cervical lymphadenopathy 0%. Laboratory data revealed white blood cell count: 15,403 +/- 6,282/mm3, hemoglobin: 10.1 +/- 1.0 gm/dl, neutrophil: 59.2 +/- 13.7%, lymphocytes: 30.6 +/- 13.1%, platelet count: 456,3000 +/- 216,4000/mm3, and C-reactive protein 8.2 +/- 5.6 mg/dl. Patients with coronary artery dilation had a longer duration of diagnosis, higher incidence of atypical presentation, lower incidence of conjunctivitis, lower incidence of skin rash, lower incidence of extremity change, and lower C-reactive protein. The predictive value of coronary artery dilation based on the combination of atypical presentation, duration of diagnosis, and C-reactive protein was 81.2%.
CONCLUSIONS: Kawasaki disease in infants is associated with a high incidence of atypical presentation and increased risk of coronary artery dilation. We suggest that in an infant with insufficient diagnostic criteria for Kawasaki disease, care should be taken to avoid missing atypical Kawasaki disease. Echocardiography is an important tool for diagnosis of atypical Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458622

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi (Taipei)        ISSN: 0578-1337


  11 in total

1.  Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease.

Authors:  Lucy Youngmin Eun; Ji Hong Kim; Jo Won Jung; Jae Young Choi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

2.  Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin.

Authors:  Noelia Moreno; Ana Méndez-Echevarría; Jaime de Inocencio; Fernando Del Castillo; Fernando Baquero-Artigao; María Jesús García-Miguel; María Isabel de José; Javier Aracil
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

3.  Incomplete Kawasaki disease with coronary artery aneurysm and coronary sinus thrombus.

Authors:  Guang Song; Weidong Ren; Zhe Liu; Dan Wu
Journal:  Pediatr Cardiol       Date:  2015-03-12       Impact factor: 1.655

4.  Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl.

Authors:  Vehbi Doğan; Erhan Karaaslan; Samet Özer; Rüveyda Gümüşer; Resul Yılmaz
Journal:  Balkan Med J       Date:  2016-07-01       Impact factor: 2.021

5.  Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.

Authors:  Yunku Yeo; TaeYeon Kim; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2008-05-14       Impact factor: 3.183

6.  Serum brain natriuretic peptide in children with Kawasaki disease.

Authors:  Yu-Ping Sun; Chao-Ping Wei; Wen-di Wang; Xing-Chang Zheng; Ye-Jun Wang; Shao-Chun Ma; Ying-Jun Xu
Journal:  World J Emerg Med       Date:  2010

7.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

8.  Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Authors:  Elizabeth S Yellen; Kimberlee Gauvreau; Masato Takahashi; Jane C Burns; Stanford Shulman; Annette L Baker; Nancy Innocentini; Chiara Zambetti; Joan M Pancheri; Adam Ostrow; Jeffrey R Frazer; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

9.  Clinical manifestations vary with different age spectrums in infants with Kawasaki disease.

Authors:  Hao-Chuan Liu; Chiao-Wei Lo; Betau Hwang; Pi-Chang Lee
Journal:  ScientificWorldJournal       Date:  2012-02-15

10.  Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study.

Authors:  Hye Jin Kang; Gee Na Kim; Hong Ryang Kil
Journal:  Korean J Pediatr       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.